<info type="GeneOrGeneProduct">Growth-associated protein 43</info> expression in <info type="OrganismTaxon">hippocampal</info> molecular layer of chronic <info type="DiseaseOrPhenotypicFeature">epileptic</info> <info type="OrganismTaxon">rats</info> treated with <info type="ChemicalEntity">cycloheximide</info>.

PURPOSE: <info type="GeneOrGeneProduct">GAP43</info> has been thought to be linked with <info type="DiseaseOrPhenotypicFeature">mossy fiber sprouting</info> (<info type="ChemicalEntity">MFS</info>) in various experimental models of <info type="DiseaseOrPhenotypicFeature">epilepsy</info>. To investigate how <info type="GeneOrGeneProduct">GAP43</info> expression (<info type="GeneOrGeneProduct">GAP43-ir</info>) correlates with <info type="DiseaseOrPhenotypicFeature">MFS</info>, we assessed the intensity (densitometry) and extension (width) of <info type="GeneOrGeneProduct">GAP43-ir</info> in the inner molecular layer of the <info type="OrganismTaxon">dentate gyrus</info> (<info type="OrganismTaxon">IML</info>) of <info type="OrganismTaxon">rats</info> subject to <info type="DiseaseOrPhenotypicFeature">status epilepticus</info> induced by <info type="ChemicalEntity">pilocarpine</info> (<info type="ChemicalEntity">Pilo</info>), previously injected or not with <info type="ChemicalEntity">cycloheximide</info> (<info type="ChemicalEntity">CHX</info>), which has been shown to inhibit <info type="DiseaseOrPhenotypicFeature">MFS</info>. METHODS: <info type="ChemicalEntity">CHX</info> was injected before the <info type="ChemicalEntity">Pilo</info> injection in adult <info type="OrganismTaxon">Wistar rats</info>. The <info type="ChemicalEntity">Pilo</info> group was injected with the same drugs, except for <info type="ChemicalEntity">CHX</info>. Animals were killed between 30 and 60 days later, and brain sections were processed for <info type="GeneOrGeneProduct">GAP43</info> immunohistochemistry. RESULTS: Densitometry showed no significant difference regarding <info type="GeneOrGeneProduct">GAP43-ir</info> in the <info type="OrganismTaxon">IML</info> between <info type="ChemicalEntity">Pilo</info>, <info type="ChemicalEntity">CHX</info>+<info type="ChemicalEntity">Pilo</info>, and control groups. However, the results of the width of the <info type="GeneOrGeneProduct">GAP43-ir</info> band in the <info type="OrganismTaxon">IML</info> showed that <info type="ChemicalEntity">CHX</info>+<info type="ChemicalEntity">Pilo</info> and control animals had a significantly larger band (p = 0.03) as compared with that in the <info type="ChemicalEntity">Pilo</info> group. CONCLUSIONS: Our current finding that animals in the <info type="ChemicalEntity">CHX</info>+<info type="ChemicalEntity">Pilo</info> group have a <info type="GeneOrGeneProduct">GAP43-ir</info> band in the <info type="OrganismTaxon">IML</info>, similar to that of controls, reinforces prior data on the blockade of <info type="DiseaseOrPhenotypicFeature">MFS</info> in these animals. The change in <info type="GeneOrGeneProduct">GAP43-ir</info> present in <info type="ChemicalEntity">Pilo</info>-treated animals was a thinning of the band to a very narrow layer just above the <info type="OrganismTaxon">granule cell layer</info> that is likely to be associated with the loss of hilar cell projections that express <info type="GeneOrGeneProduct">GAP-43</info>.